Fluorescence in situ DNA hybridization (FISH) and quantitative real time PCR have been demonstrated to be valuable tools for target gene discovery within identified chromosomal regions of gain, e.g. the TLOC1/SEC62 gene at 3q26.2 in prostate cancer [6]. Here, SEC62 is linked to prostate carcinoma.